These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 740428)

  • 21. [Hemodynamic effects of an osmotic bolus for the reversible opening of the blood-brain barrier].
    Hiesmayr M; Dirnberger H; Aloy A; Heimberger K; Horaczek A; Brandstätter B; Zimpfer M
    Schweiz Med Wochenschr; 1987 Mar; 117(12):450-4. PubMed ID: 3107120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Temporary hyperosmolar breakage of the blood-brain barrier improves effectiveness of chemotherapy for cerebral tumors].
    Aronov MS; Kobiakov GL; Lubnin AIu; Iakovlev SB
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (3):52-9. PubMed ID: 19062597
    [No Abstract]   [Full Text] [Related]  

  • 23. Brain tumors: controversies and challenges in management.
    Lesniak MS
    Expert Rev Neurother; 2005 Nov; 5(6 Suppl):1-2. PubMed ID: 16274264
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemotherapy of primary cerebral lymphoma].
    Delwail V; Bataille B
    Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system.
    Mellett LB
    Cancer Treat Rep; 1977 Jul; 61(4):527-31. PubMed ID: 884690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
    Neuwelt EA; Frenkel EP; D'Agostino AN; Carney DN; Minna JD; Barnett PA; McCormick CI
    Cancer Res; 1985 Jun; 45(6):2827-33. PubMed ID: 2985254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy of malignant brain tumors: biology and pharmacokinetics (author's transl)].
    Hoshino T
    No Shinkei Geka; 1980 Nov; 8(11):1007-16. PubMed ID: 7005704
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy.
    Dahlborg SA; Henner WD; Crossen JR; Tableman CM; Petrillo A; Braziel R; Neuwelt EA
    Cancer J Sci Am; 1996; 2(3):166-74. PubMed ID: 9166517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.
    Cosolo W; Christophidis N
    Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy and the treatment of brain metastases.
    Peak S; Abrey LE
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1287-95. PubMed ID: 17113463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
    Shapiro WR; Ausman JI; Rall DP
    Cancer Res; 1970 Sep; 30(9):2401-13. PubMed ID: 5475484
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm.
    Gerstner ER; Fine RL
    J Clin Oncol; 2007 Jun; 25(16):2306-12. PubMed ID: 17538177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognosis of acute leukaemia in childhood.
    O'Gorman Hughes DW
    Med J Aust; 1974 Jun; 1(25):991-4. PubMed ID: 4528054
    [No Abstract]   [Full Text] [Related]  

  • 35. Biology and therapy of glial tumors.
    Weingart J; Brem H
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):808-12. PubMed ID: 1467571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain-barrier disruption interventional neuroradiology in brain tumor therapy.
    Heimberger K; Samec P; Binder H; Horaczek A; Mutz N
    Ann Radiol (Paris); 1986; 29(2):230-2. PubMed ID: 3090924
    [No Abstract]   [Full Text] [Related]  

  • 37. [Various methodologic principles in the chemotherapy of malignant brain tumors].
    Romodanov AP; Sosnov IuD
    Vopr Neirokhir; 1973; 37(5):14-8. PubMed ID: 4591507
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chemotherapy in infantile brain tumors].
    Bezanilla Regato JL
    An Esp Pediatr; 1992 Jun; 36 Suppl 49():224-6. PubMed ID: 1416475
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
    Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
    J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings: Factors influencing the outcome of chemotherapy of brain tumors.
    Ausman JI
    Proc Natl Cancer Conf; 1972; 7():805-9. PubMed ID: 4764938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.